Blackstone Inc
CGON icon

Blackstone Inc’s CG Oncology CGON Stock Holding History

Blackstone Inc’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$308K Sell
4,335
-59,793
-93% -$3.91M ﹤0.01% 446
2026
Q1 		$4.34M Buy
+64,128
New +$3.63M 0.02% 137
2024
Q2 		– Sell
-25,000
Closed -$1.1M – 182
2024
Q1 		$1.1M Buy
+25,000
New +$1.02M ﹤0.01% 138

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Blackstone Inc's CGON Position: Q2 2026 in Review

Blackstone Inc reduced its CG Oncology (CGON) stake by 93% in Q2 2026, selling an estimated $3.91M and leaving 4,335 shares worth $308K. The position accounts for ﹤0.01% of the portfolio, ranked #446.

Blackstone Inc first reported a position in CGON in Q1 2024 and has held it in 3 quarters since. The position peaked at $4.34M in Q1 2026. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Blackstone Inc held 4,335 shares of CG Oncology worth $308K as of Q2 2026.
  • Blackstone Inc sold 59,793 CG Oncology shares in Q2 2026, an estimated $3.91M.
  • CG Oncology made up ﹤0.01% of Blackstone Inc's portfolio in Q2 2026, its #446 holding.
  • Blackstone Inc first reported a position in CG Oncology in Q1 2024 and has held it in 3 quarters since.
  • Blackstone Inc's CG Oncology position peaked at $4.34M in Q1 2026.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Blackstone Inc's 13F filing for Q2 2026, filed 14 Aug 2026.